文献速递前列腺癌

经会阴前列腺融合穿刺中四点靶向穿刺与九点靶饱和穿刺检测临床显著前列腺癌:一项前瞻性随机试验

Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial.
PubMed 文献 · Eur Urol Oncol · 2022-09-26

这项前瞻性单中心随机试验纳入170例接受经会阴MRI/TRUS融合前列腺穿刺的男性,比较传统四点靶向穿刺(TB)与九点靶饱和穿刺(TS)对临床显著前列腺癌(csPC)的检出率。以靶向穿刺联合系统穿刺为参考,TS组检出57/57例csPC,TB组检出33/36例(p=0.058),两组csPC检出率无显著差异。

要点

  • TS组检出57/57例csPC,TB组检出33/36例,差异未达统计学显著(p=0.058)。
  • Gleason分级组1检出:TS组10/12例,TB组8/17例(p=0.055)。
  • TS检出63个csPC病灶中的97%,TB检出86%(p=0.1)。

核心结论

  • 在本研究中,TS与TB的csPC检出率无显著差异。

研究设计与样本

  • 前瞻性单中心研究,纳入170例接受经会阴MRI/TRUS融合前列腺穿刺的男性。
  • 85例随机分配至传统四点靶向穿刺(TB),85例分配至九点靶饱和穿刺(TS)。
  • 穿刺由三名经验丰富的委员会认证泌尿外科医生操作。

主要发现

  • 以靶向穿刺联合系统穿刺为参考,TS组诊断57例csPC,TB组诊断36例。
  • TS检出57/57例csPC,TB检出33/36例(p=0.058)。
  • Gleason分级组1检出:TS组10/12例,TB组8/17例(p=0.055)。
  • TS检出63个csPC病灶中的97%,TB检出86%(p=0.1)。

关键数值与推荐

  • csPC定义为国际泌尿病理学会分级组≥2。
  • 系统穿刺、TB和TS的PC及csPC检出率采用McNemar检验进行患者内比较,TS与TB比较采用Fisher精确检验。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 单中心设计。
  • 经会阴穿刺途径导致普遍性受限。
  • 缺乏病理中心复核及根治性前列腺切除病理对照。
  • 两组间csPC患病率、PI-RADS 5病灶、具有两个及以上PI-RADS≥3病灶的男性及前列腺特异性抗原密度分布不均,可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy (TB) facilitate accurate detection of clinically significant prostate cancer (csPC). However, it remains unclear how targeted cores should be applied for accurate diagnosis of csPC. OBJECTIVE: To assess csPC detection rates for two target-directed MRI/transrectal ultrasonography (TRUS) fusion biopsy approaches, conventional TB and target saturation biopsy (TS). DESIGN, SETTING, AND PARTICIPANTS: This was a prospective single-center study of outcomes for transperineal MRI/TRUS fusion biopsies for 170 men. Half of the men (n = 85) were randomized to conventional TB with four cores per lesion and half (n = 85) to TS with nine cores. Biopsies were performed by three experienced board-certified urologists. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: PC and csPC (International Society of Urological Pathology grade group ≥2) detection rates for systematic biopsy (SB), TB, and TS were analyzed using McNemar's test for intrapatient comparisons and Fisher's exact test for TS versus TB. A combination of targeted biopsy (TS or TB) and SB served as the reference. RESULTS AND LIMITATIONS: According to the reference, csPC was diagnosed for 57 men in the TS group and 36 men in the TB group. Of these, TS detected 57/57 csPC cases and TB detected 33/36 csPC cases (p = 0.058). Detection of Gleason grade group 1 disease was 10/12 cases with TS and 8/17 cases with TB (p = 0.055). In addition, TS detected 97% of 63 csPC lesions, compared to 86% with TB (p = 0.1). Limitations include the single-center design, the limited generalizability owing to the transperineal biopsy route, the lack of central review of pathology and radical prostatectomy correlation, and uneven distributions of csPC prevalence, Prostate Imaging-Reporting and Data System (PI-RADS) 5 lesions, men with two or more PI-RADS ≥3 lesions, and prostate-specific antigen density between the groups, which may have affected the results. CONCLUSIONS: In our study, rates of csPC detection did not significantly differ between TS and TB. PATIENT SUMMARY: In this study, we investigated two targeted approaches for taking prostate biopsy samples after observation of suspicious lesions on prostate scans. We found that the rates of detection of prostate cancer did not significantly differ between the two approaches.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Saner YM, Wiesenfarth M, Weru V, et al. Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial. Eur Urol Oncol. 2022. PMID: 36175281. doi:10.1016/j.euo.2022.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。